Daniel Krewski, Patrick Saunders-Hastings, Robert A. Baan, et al. Development of an Evidence-Based Risk Assessment Framework. ALTEX. 2022;39(4):667-693. doi:10.14573/altex.2004041
Ivan Rusyn, Courtney Sakolish, Yuki Kato, et al. Microphysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing Consortium. Toxicological Sciences: An Official Journal of the Society of Toxicology. 2022;188(2):143-152. doi:10.1093/toxsci/kfac061
Merel Ritskes-Hoitinga, Pandora Pound. The role of systematic reviews in identifying the limitations of preclinical animal research, 2000-2022: part 1. Journal of the Royal Society of Medicine. 2022;115(5):186-192. doi:10.1177/01410768221093551
Merel Ritskes-Hoitinga, Pandora Pound. The role of systematic reviews in identifying the limitations of preclinical animal research, 2000-2022: part 2. Journal of the Royal Society of Medicine. 2022;115(6):231-235. doi:10.1177/01410768221100970
Manuela Cassotta, Hugo Geerts, Lise Harbom, et al. The future of Parkinson’s disease research: A new paradigm of human-specific investigation is necessary… and possible. ALTEX. 2022;39(4):694-709. doi:10.14573/altex.2203161
Anna J. van der Zalm, João Barroso, Patience Browne, et al. A framework for establishing scientific confidence in new approach methodologies. Archives of Toxicology. 2022;96:2865-2879. doi:10.1007/s00204-022-03365-4
Dan Shu, Meiying Shen, Kang Li, et al. Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy. Annals of Medicine. 2022;54(1):2581-2597. doi:10.1080/07853890.2022.2122550
Drew E. Glaser, Matthew B. Curtis, Peter A. Sariano, et al. Organ-on-a-chip model of vascularized human bone marrow niches. Biomaterials. 2022;280:121245. doi:10.1016/j.biomaterials.2021.121245